Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D.L. Bowtell, Frances R. Balkwill, Filipe Correia Martins et al.|Nature reviews. Cancer|2015Cited by 1.4k
A single-cell landscape of high-grade serous ovarian cancerBenjamin Izar, Aviv Regev, Itay Tirosh et al.|Nature Medicine|2020Cited by 522
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix depositionMarcin Iwanicki, Joan S. Brugge|JCI Insight|2016Cited by 60
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular VesiclesMikołaj Piotr Zaborowski, Xandra O. Breakefield, Kyungheon Lee et al.|Cell Reports|2019Cited by 46
Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell ProtectionDaniel Centeno, Marcin Iwanicki|Nutrients|2024Cited by 9